News

Researchers explore individuals' confidence or reluctance to vaccinate their families and the associated effects on global health, in a collection published on Feb. 25 by the open-access journal, PLOS Currents: Outbreaks. The collection is accompanied by the editorial "Hesitancy, trust and individualism in vaccination decision-making" by Jonathan E. Suk et al. from the European Centre for Disease Prevention and Control (ECDC).

Researchers at the University of Georgia have developed a new small molecule drug that may serve as a treatment against multidrug-resistant tuberculosis, a form of the disease that cannot be cured with conventional therapies. They describe their findings in a paper published recently in Bioorganic and Medicinal Chemistry Letters.

Every day, every bed in an Ebola treatment unit creates approximately 300 liters of liquid waste. Managing this waste has been a challenge in the Ebola outbreak in Liberia. The World Health Organization (WHO) is working with partners to ensure this waste is effectively decontaminated and no longer poses a threat to health.

Virginia Tech biochemists are trying to deliver a stern wake-up call to the parasite that causes sleeping sickness. Scientists identified a protein, called proliferating cell nuclear antigen or PCNA, that is vital to the sleeping sickness parasite’s good health. Disrupting this protein with drugs could potentially make it impossible for the parasite to reproduce and survive, reducing the health dangers to its human hosts.